Børresen-Dale AL - Search Results

1

TP53 mutations in synchronous and metachronous bilateral breast carcinomas.

Suspitsin EN, Due EU, Vu P, Hirvonen A, Børresen-Dale AL, Imyanitov EN. Suspitsin EN, et al. Cancer Genet Cytogenet. 2008 Jul 15;184(2):119-21. doi: 10.1016/j.cancergencyto.2008.03.005. Cancer Genet Cytogenet. 2008. PMID: 18617062 No abstract available.

2

Paired distribution of molecular subtypes in bilateral breast carcinomas.

Russnes HG, Kuligina ESh, Suspitsin EN, Voskresenskiy DA, Jordanova ES, Cornelisse CJ, Borresen-Dale AL, Imyanitov EN. Russnes HG, et al. Cancer Genet. 2011 Feb;204(2):96-102. doi: 10.1016/j.cancergencyto.2010.09.012. Cancer Genet. 2011. PMID: 21504707

3

Nonrandom distribution of oncogene amplifications in bilateral breast carcinomas: Possible role of host factors and survival bias.

Suspitsin EN, Sokolenko AP, Togo AV, Lazareva YR, Turkevich EA, Matsko DE, Henrich KO, Borresen-Dale AL, Schwab M, Cornelisse CJ, Imyanitov EN. Suspitsin EN, et al. Int J Cancer. 2007 Jan 15;120(2):297-302. doi: 10.1002/ijc.22265. Int J Cancer. 2007. PMID: 17066426 Free article.

4

Full sequencing of TP53 identifies identical mutations within in situ and invasive components in breast cancer suggesting clonal evolution.

Zhou W, Muggerud AA, Vu P, Due EU, Sørlie T, Børresen-Dale AL, Wärnberg F, Langerød A. Zhou W, et al. Mol Oncol. 2009 Jun;3(3):214-9. doi: 10.1016/j.molonc.2009.03.001. Epub 2009 Apr 2. Mol Oncol. 2009. PMID: 19403344 Free PMC article.

5

Evaluation of arrayed primer extension for TP53 mutation detection in breast and ovarian carcinomas.

Kringen P, Bergamaschi A, Due EU, Wang Y, Tagliabue E, Nesland JM, Nehman A, Tönisson N, Børresen-Dale AL. Kringen P, et al. Biotechniques. 2005 Nov;39(5):755-61. doi: 10.2144/000112000. Biotechniques. 2005. PMID: 16312222 Free article.

6

A comparison between p53 accumulation determined by immunohistochemistry and TP53 mutations as prognostic variables in tumours from breast cancer patients.

Alsner J, Jensen V, Kyndi M, Offersen BV, Vu P, Børresen-Dale AL, Overgaard J. Alsner J, et al. Acta Oncol. 2008;47(4):600-7. doi: 10.1080/02841860802047411. Acta Oncol. 2008. PMID: 18465328

7

Screening breast cancer patients for Norwegian ATM mutations.

Laake K, Vu P, Andersen TI, Erikstein B, Kåresen R, Lonning PE, Skovlund E, Børresen-Dale AL. Laake K, et al. Br J Cancer. 2000 Dec;83(12):1650-3. doi: 10.1054/bjoc.2000.1519. Br J Cancer. 2000. PMID: 11104561 Free PMC article.

8

Mutation screening of the TP53 gene by temporal temperature gradient gel electrophoresis.

Sørlie T, Johnsen H, Vu P, Lind GE, Lothe R, Børresen-Dale AL. Sørlie T, et al. Methods Mol Biol. 2005;291:207-16. doi: 10.1385/1-59259-840-4:207. Methods Mol Biol. 2005. PMID: 15502225

9

Mutation screening of the TP53 gene by temporal temperature gel electrophoresis (TTGE).

Sørlie T, Johnsen H, Vu P, Lind GE, Lothe R, Børresen-Dale AL. Sørlie T, et al. Methods Mol Biol. 2014;1105:315-24. doi: 10.1007/978-1-62703-739-6_25. Methods Mol Biol. 2014. PMID: 24623239

10

High-resolution analyses of copy number changes in disseminated tumor cells of patients with breast cancer.

Mathiesen RR, Fjelldal R, Liestøl K, Due EU, Geigl JB, Riethdorf S, Borgen E, Rye IH, Schneider IJ, Obenauf AC, Mauermann O, Nilsen G, Christian Lingjaerde O, Børresen-Dale AL, Pantel K, Speicher MR, Naume B, Baumbusch LO. Mathiesen RR, et al. Int J Cancer. 2012 Aug 15;131(4):E405-15. doi: 10.1002/ijc.26444. Epub 2011 Nov 9. Int J Cancer. 2012. PMID: 21935921 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

508 results

Search Page